18 results
8-K
EX-99.1
ARVN
Arvinas Inc
5 May 23
Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:30am
neurons, while sparing wild-type HTT.
Appointed Kelly Page as Senior Vice President, Global Head of Oncology Strategy and Program Leadership
8-K
EX-99.1
ARVN
Arvinas Inc
16 Dec 22
Arvinas Announces Changes to its Board of Directors
9:02am
Executive Officer at Arvinas. “We will miss him and his inspiring leadership, and we wish him the best of luck in his future endeavors.”
Mr. Cunningham … joins Arvinas’ Board with over 25 years of experience in pharmaceuticals and medical services and a commitment to leadership excellence. He currently
8-K
EX-99.1
gv18ofldj4s7 mokzj
3 Nov 21
Arvinas Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:01pm
8-K
EX-99.1
lugjo7cjvzgx rfc
5 Aug 21
Arvinas Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-99.1
bx8ky8aflo imrteexx
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-99.1
828tgtxg8eghjletqs
4 May 21
Arvinas Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-99.2
kgruw
23 Oct 19
Arvinas Presents a Platform Update, Including Initial Data from the First Two Clinical Trials of PROTAC® Targeted Protein Degraders
6:39am
8-K
EX-99.1
d85w 1c6w93
5 Aug 19
Arvinas Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:05pm
DEF 14A
ia4nyj3yk4t n45wljcw
12 Apr 19
Definitive proxy
5:02pm
DRS/A
03vbo2kixa kx
2 Aug 18
Draft registration statement (amended)
12:00am
DRS
91jygd
22 Jun 18
Draft registration statement
12:00am
- Prev
- 1
- Next